Proc Natl Acad Sci USA 105(43):1667716682
SLICK DESIGN LOVE: The DSi keeps roughly the same dimensions as the DS Lite while slightly increasing the screen size (the new touchscreen measures about 1.96 inches by 2.59 inches
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Most people tolerate IV therapy well, but mild side effects like bruising at the injection site, mild discomfort, or allergic reactions to certain ingredients may occur
doi: 10.1016/j.ijpharm.2013.02.040
The wide variance exists because clinical research used wildly different protocols
